Stephen J Schuster, MD¹, Nathan Fowler, MD^2,3, Michael Dickinson, MBBS, D. Med Sci, FRACP, FRCPA⁴, Joaquin Martinez-Lopez, MD, PhD^5*, Arne Kolstad, MD, PhD^6*, Jason Butler, MBBS^7*, Monalisa Ghosh, MD⁸, Leslie L. Popplewell, MD, FACP, MPH⁹, Julio C Chavez, MD¹⁰, Emmanuel Bachy, MD, PhD^11*, Koji Kato, M.D., Ph.D.^12*, Hideo Harigae¹³, Marie José Kersten, MD, PhD¹⁴, Charalambos Andreadis^15*, Peter A Riedell^16*, Phoebe Joy Ho, MBBS, FRACP, FRCPA¹⁷, Jose A. Perez-Simon, MD, PhD^18*, Andy Chen, MD, PhD¹⁹, Loretta J. Nastoupil, MD², Bastian von Tresckow, MD^20,21, Andrés José María Ferreri, MD²², Takanori Teshima^23*, Piers Patten, FRCP, FRCPath, PhD²⁴, Joseph P McGuirk, DO²⁵, Andreas L Petzer, MD^26*, Fritz Offner, MD²⁷, Andreas Viardot, MD PhD²⁸, Pier Luigi Zinzani, MD, PhD^29,30, Ram Malladi, PhD^31*, Aiesha Zia^32*, Rakesh Awasthi, PhD^33*, Ines Paule^32*, Davide Germano^32*, Roberto Javier Ramos, MD^34*, Pei Hsu^35*, Catherine Thieblemont, MD^36* and Martin Dreyling, MD³⁷

¹Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²The University of Texas MD Anderson Cancer Center, Houston, TX
³BostonGene, Corp., Waltham, MA
⁴Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia
⁵Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
⁶Oslo University Hospital, Oslo, Norway
⁷Royal Brisbane Hospital, Herston, QLD, Australia
⁸Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁹Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
¹⁰Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹¹Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France
¹²Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
¹³Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
¹⁴Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹⁵Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
¹⁶David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
¹⁷Royal Prince Alfred Hospital, Sydney, AUS
¹⁸Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
¹⁹Oregon Health and Science University, Portland, OR
²⁰Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
²¹Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
²²Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
²³Department of Hematology, Hokkaido University, Sapporo, Japan
²⁴King’s College London, London, GBR
²⁵University of Kansas Medical Center, Westwood, KS
²⁶Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria
²⁷Universitair Ziekenhuis Gent, Gent, Belgium
²⁸Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²⁹Universitaria di Bologna, Istituto Di Ematologia, Bologna, ITA
³⁰Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
³¹Hospitals NHS Foundation Trust, Cambridge University, Cambridge, United Kingdom
³²Novartis Pharma AG, Basel, CHE
³³Novartis Pharmaceuticals, East Hanover, NJ
³⁴Novartis Pharmaceuticals Corporation, East Hanover, NJ
³⁵Novartis Pharma AG, Basel, Switzerland
³⁶Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France
³⁷Department of Medicine, Medical Clinic III, Ludwig-Maximilians-University Hospital, Munich, Germany

Franck Morschhauser, phd¹, Saurabh Dahiya^2*, Maria Lia Palomba, MD³, Alejandro Martin Garcia-Sancho, MD^4*, Juan Luis Reguera, MD^5,6*, John Kuruvilla, MD, FRCPC⁷, Ulrich Jaeger, MD^8*, Guillaume Cartron, MD, Ph-D^9*, Koji Izutsu, MD, PhD¹⁰, Martin Dreyling, MD¹¹, Brad S. Kahl, MD¹², Herve Ghesquieres, MD^13*, Kirit Ardeshna, MD, MA, FRCP^14*, Hideki Goto, MD, PhD^15*, Anna Maria Barbui, MD^16*, Jeremy S. Abramson, MD¹⁷, Peter Borchmann, MD¹⁸, Isabelle Fleury, MD¹⁹, Stephan Mielke, MD²⁰, Alan Skarbnik, MD^21,22, Sven de Vos, MD, PhD^23*, Manali Kamdar, MD^24*, Reem Karmali, MD, MSc²⁵, Andreas Viardot, MD PhD²⁶, Thalia Farazi²⁷, Omotayo Fasan²⁸, James Lymp, PhD^29*, Min Vedal, PhD^29*, Rina Nishii, PhD^28*, Ariel Avilion, PhD^29*, Jessica Papuga, PhD^30* and Loretta J. Nastoupil, MD³¹

¹CHU de Lille, Lille, France
²Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain
⁵University Hospital Virgen del Rocío, Sevilla, Spain
⁶Instituto de Biomedicina de Sevilla (IBIS), Servicio de Hematología, Hospital Universitario Virgen del Rocío and Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla, Sevilla, Spain
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Medical University of Vienna, Vienna, Austria
⁹Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
¹⁰National Cancer Center Hospital, Tokyo, Japan
¹¹Medizinische Klinik III, Klinikum der Universität, LMU München, Munich, Germany
¹²Washington University School of Medicine in St. Louis, St. Louis, MO
¹³Hôpital Lyon Sud, Lyon, France
¹⁴University College London Hospitals NHS Foundation Trust - University College Hospital, London, United Kingdom
¹⁵Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
¹⁶Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
¹⁷Massachusetts General Hospital Cancer Center, Boston, MA
¹⁸Universität zu Köln, Köln, Germany
¹⁹Hôpital Maisonneuve – Rosemont, Montreal, QC, Canada
²⁰Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Stockholm, Sweden
²¹Novant Health Cancer Institute, Lymphoma and CLL Program, Charlotte, NC
²²Novant Health Cancer Institute, Charlotte, NC
²³UCLA Santa Monica Medical Centre, Santa Monica, CA
²⁴University of Colorado Cancer Center, Aurora, CO
²⁵Northwestern University Feinberg School of Medicine, Chicago, IL
²⁶Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²⁷Bristol Myers Squibb, San Francisco, CA
²⁸Bristol Myers Squibb, Princeton, NJ
²⁹Bristol Myers Squibb, Seattle, WA
³⁰Bristol Myers Squibb, Boudry, Switzerland
³¹The University of Texas MD Anderson Cancer Center, Houston, TX

Stephen J. Schuster, MD¹, Laurie H. Sehn, MD, MPH², Nancy L. Bartlett, MD³, Matthew Matasar, MD, MS⁴, Sarit Assouline, MD⁵, Pratyush Giri, MBBS^6*, John Kuruvilla, MD^7*, Mazyar Shadman, MD, MPH^8*, Chan Y. Cheah, MBBS^9,10, Sascha Dietrich, MD^11*, Keith Fay, MBChB, FRACP, FRCPA^12*, Matthew Ku, MBBS^13*, Loretta J. Nastoupil, MD¹⁴, Michael C. Wei, MD, PhD¹⁵, Shen Yin, PhD^15*, Iris To, PharmD^15*, Jiangeng Huang, PhD^15*, Antonia Kwan, MBBS, PhD^15*, Elicia Penuel, PhD¹⁵ and Elizabeth Lihua Elizabeth Budde, MD, PhD¹⁶

¹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
²BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
³Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
⁵Jewish General Hospital, Montreal, QC, Canada
⁶Royal Adelaide Hospital, Adelaide, Australia
⁷Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA
⁹The University of Western Australia, Perth, Australia
¹⁰Linear Clinical Research, Sir Charles Gairdner Hospital, Nedlands, Australia
¹¹Heidelberg University Hospital, Heidelberg, Germany
¹²St Vincent's Hospital and Royal North Shore Hospital, Sydney, Australia
¹³St Vincent's Hospital, University of Melbourne, Melbourne, Australia
¹⁴MD Anderson Cancer Center, Houston, TX
¹⁵Genentech, Inc., South San Francisco, CA
¹⁶City of Hope National Medical Center, Duarte, CA

Lorenzo Falchi, MD¹, Michelle Okwali, MPH^1*, Paola Ghione, MD, MSEpi², Colette Owens, MD³, Paul A. Hamlin, MD¹, Jennifer Kimberly Lue, MD³, Zachary D. Epstein-Peterson, MD³, Maria Lia Palomba, MD¹, Anita Kumar, MD², Pallawi Torka, MD³, Lori A. Leslie, MD⁴, Alexandra Ferreira Lopes, BS^2*, Anastasia Martinova, BSN, RN^5*, Lauren Wood, MSN, RN, AGCNS-BC, OCN^5*, Clare Grieve, MPH^2*, Walter Ramos Amador, MPH, MS^2*, Santosha A Vardhana, MD, PhD^1*, Andrew D. Zelenetz, MD, PhD³ and Gilles Salles, MD, PhD³

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
²Memorial Sloan Kettering Cancer Center, New York, NY
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian School of Medicine, Hackensack, NJ
⁵Memorial Sloan Kettering Cancer Center, New York

Franck Morschhauser, MD PhD¹, Krish Patel^2*, Sabela Bobillo, MD, PhD^3*, Raul Cordoba, MD, PhD⁴, Toby A. Eyre^5*, Mark Bishton, MD, PhD^6*, Roch Houot, MD, PhD^7*, Hui-Lai Zhang, MD^8*, Liqun Zou, MD, PhD^9*, Wendy Osborne, MD^10*, Laura Gálvez-Carvajal, MD, PhD^11*, Catherine Thieblemont, MD^12*, Donald Yee, MD^13*, Andrea Knapp, PhD^14*, Enkhtsetseg Purev, MD, PhD^13*, Haocheng Li, PhD^15*, Vivian Chen, PharmD^13*, Karl L. Banta, PhD^13*, Jason Sit, PharmD, PhD^13* and Emmanuel Bachy, MD, PhD^16*

¹University of Lille, CHU Lille, Lille, France
²Swedish Cancer Institute, Seattle, WA
³Hospital Universitario Valle de Hebrón, Barcelona, Spain
⁴Health Research Institute IIS-FJD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁵Oxford University Hospitals NHS Trust, Oxford, United Kingdom
⁶Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁷CHU de Rennes, Université de Rennes, INSERM U1236, EFS, Rennes, France
⁸Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁹West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
¹⁰Freeman Hospital, Newcastle upon Tyne, United Kingdom
¹¹Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Malaga, Spain
¹²Hôpital Saint-Louis, Paris, France
¹³Genentech, Inc., South San Francisco, CA
¹⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁵Hoffmann-La Roche Limited, Mississauga, ON, Canada
¹⁶Department of Hematology, Hospices Civils de Lyon, Lyon, France

Jonathan W. Friedberg, MD, MMSc¹, Michael T. Brady^2*, Strawderman Myla, MS^3*, Brad S. Kahl, MD⁴, Izidore S. Lossos, MD⁵, Jonathon B. Cohen, MD, MS⁶, Patrick M. Reagan, MD⁷, Carla Casulo, MD², Barbara L. Averill, BSN, RN^8*, Brian K. Link, MD^9*, Paul M. Barr, MD⁷, John P. Leonard¹⁰, John M. Ashton, PhD, MBA^7*, Derick R Peterson, PhD^11* and Loretta J. Nastoupil, MD¹²

¹University of Rochester, Rochester, NY
²Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
³Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY
⁴Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
⁵Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
⁶Winship Cancer Institute, Emory University, Atlanta, GA
⁷Wilmot Cancer Institute, University of Rochester, Rochester, NY
⁸Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
⁹Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
¹⁰Weill Cornell Medicine, New York, NY
¹¹Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY
¹²MD Anderson Cancer Center, Houston, TX